Clinical trial
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the…
NCT00385606 · National Cancer Institute, Naples, Other · Completed
Key facts
| NCT number | NCT00385606 |
|---|---|
| Title | Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC |
| Official title | Phase II-III, Factorial Multicenter Randomized Trial Evaluating the Addition of Rofecoxib to Polycht With Cispatin and Gemcitabine and Fixed Dose Rate Infusion of Gem in Association With Cisplatin in 1st-line for Advanced NSCLC |
| Lead sponsor | National Cancer Institute, Naples, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Advanced Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine, prolonged continuous infusion gemcitabine, cisplatin, rofecoxib |
| Enrollment | 400 |
| Start date | Jan 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Oct 11, 2006 |
| Last update posted | Mar 23, 2023 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: